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High-throughput gene expression technologies such as microarrays have been utilized in a variety of scientiﬁc applications. Most
of the work has been done on assessing univariate associations between gene expression proﬁles with clinical outcome (variable
selection) or on developing classiﬁcation procedures with gene expression data (supervised learning). We consider a hybrid variable
selection/classiﬁcation approach that is based on linear combinations of the gene expression proﬁles that maximize an accuracy
measure summarized using the receiver operating characteristic curve. Under a speciﬁc probability model, this leads to the consid-
eration of linear discriminant functions. We incorporate an automated variable selection approach using LASSO. An equivalence
between LASSO estimation with support vector machines allows for model ﬁtting using standard software. We apply the proposed
method to simulated data as well as data from a recently published prostate cancer study.
INTRODUCTION
DNA microarrays simultaneously gauge the expres-
sion of thousands of genes in clinical samples. In this pa-
per, we focus on cancer studies, where gene expression
technologies have been applied extensively (Alizadeh et al
[1]; Khan et al [2]; Dhanasekaran et al [3]). Obtaining
large-scale gene expression proﬁles of tumors should the-
oretically allow for the identiﬁcation of subsets of genes
that function as prognostic disease markers or biologic
predictors of therapeutic response. Because the data are
highly multivariate and complex, it is important to de-
velop automated statistical methods to detect systematic
signals in gene expression patterns.
In cancer studies, analyses have typically focused on
one of three problems. First, investigators have looked for
genesthatdiscriminateneoplasticfrombenigntissue.Sta-
tistically, this is the problem assessing diﬀerential expres-
sion of genes and has been studied by several authors; see,
for example, Efron et al [4]. A second problem is clus-
tering the samples to ﬁnd subtypes of disease using algo-
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rithms such as those in [5]. The ﬁnal class of problems
is classiﬁcation or supervised learning, which involves us-
ing the proﬁle to predict some clinical outcome, such as
the stage of disease. Suppose that in this instance, we treat
the gene expression proﬁle as the independent variables
and tissue type as the response. A particular feature of
microarray experiments is that the dimension of the pre-
dictor space (number of genes) is typically larger than the
number of samples. This is known as the “large p,s m a l l
n” paradigm (West [6]), so classiﬁcation methods must
take this into account.
One method to do this is apply preﬁltering criteria in
which the candidate number of genes for building a clas-
siﬁer is smaller than the number of samples. For exam-
ple, Dudoit et al [7]p e r f o r m e das y s t e m a t i cc o m p a r i s o n
of several discrimination methods for the classiﬁcation of
tumors based on microarray experiments. However, they
must perform an initial reduction in the number of pre-
dictors before building the classiﬁer.
We wish to consider the joint eﬀects of genes in
determining classiﬁcation rules for discriminating tu-
mors. There are two assumptions that drive our pro-
posed methodology. First, we assume that the joint eﬀects
of multiple genes must be considered in discriminating
classes of disease. Recently, much attention has been given
to the ﬁnding that a 70-gene signature can predict breast
cancer survival (van’t Veer et al [8]; van de Vijver et al
[9]). However, most such gene signatures have been con-
structed using univariate methods. It seems reasonable to
consider joint models, as genes are correlated because of
their mutual involvement in disease pathways.148 D. Ghosh and A. M. Chinnaiyan 2005:2 (2005)
The second assumption is that there are individual
genes that can discriminate classes. This is diﬀerent from
the latent factor and partial least squares proposals put
forth by other authors (West [6]; Nguyen and Rocke
[10]), where linear combinations of all available genes are
used to predict the outcome. We seek to develop inter-
pretable models for classiﬁcation; for this purpose, using
individual genes for predictors rather than linear combi-
nations of genes seems reasonable.
In this paper, we develop classiﬁcation rules based on
the consideration of measures of diagnostic accuracy. In
particular, we are interested in ﬁnding gene expression
proﬁles that can discriminate between two populations.
A unique challenge is posed because of the large p,s m a l l
n problem. Our solution is to combine the problems of
variable selection and classiﬁcation. We suggest an ap-
proach for classiﬁcation using the LASSO approach (Tib-
shirani [11]). An advantage of this approach is that some
oftheeﬀectsofthevariablesinthesemodelsareestimated
to be exactly zero. These will represent genes that have
no discriminatory power between the two classes, while
those with nonzero coeﬃcients will represent genes that
can separate classes of tumors successfully. Thus, a by-
product of the approach is the generation of a gene list.
We exploit an equivalence between LASSO and support
vector machines (SVMs) in order to ﬁt the proposed clas-
siﬁer.Thestructureofthepaperisasfollows.In“materials
and methods,” we provide background on the data struc-
tures observed and the motivation based on biomarker
combinations, which leads to the use of linear discrim-
inant functions. We also provide a review of LASSO es-
timation (Tibshirani [11]) in this section. The latter two
techniques are then involved in the proposed estimation
procedure, described in “results and discussion.” There,
we also describe how to implement the proposed method
using software for SVMs. Issues of model selection are
also discussed. We describe the application of the pro-
posed methodologies to simulated data and data from a
recent cancer proﬁling study (Dhanasekaran et al [3]) in
“prostate cancer gene expression data.” Finally, some con-
cluding remarks are made in “conclusion.”
MATERIALS AND METHODS
Let aT denote the transpose of the vector a. For the ith
sample (i = 1,...,n), we let Xi = [Xi1 ···Xip]T denote
the p ×1 gene expression proﬁle vector (ie, Xij is the gene
expression measurement of the jth gene, j = 1,...,p).
We suppose that the data have already been preprocessed
and normalized. In addition, it is assumed that the gene
expression data are standardized so that for each gene, the
meaniszeroandstandarddeviationone.Letgi denotethe
tumor class for the ith sample (i = 1,...,n); we assume
that there are two classes so that gi takes values g ∈{ 0,1}.
Here and in the sequel, we will refer to g = 1 as the dis-
eased class and g = 0 as the healthy class; however, the
methods proposed here are applicable to any two-class
setting. In “LASSO estimation,” we assume the existence
of a continuous response variable Yi for the ith sample
(i = 1,...,n).
ROCcurvesandoptimalbiomarkercombinations
Ourapproachistoconsidereachmeasurementfroma
microarray for a single gene as a diagnostic test. Thus, for
each subject, we have a high-dimensional vector of diag-
nostictestresults.Wethenwanttoutilizethisinformation
in a way to separate the two populations of patients. This
issue of ﬁnding combinations of biomarkers to accurately
classify patients has been considered by Su and Liu [12],
Baker [13], and Pepe and Thompson [14] in the statistical
literature.
To combine information across the high-dimensional
vectorofgeneexpressionproﬁles,weconsiderlinearcom-
binations of the form βT
0 Xi, i = 1,...,n. Without loss
of generality, we will also assume that larger values of
this linear combination corresponding to increasing like-
lihood of having g = 1. While the method can be eas-
ily extended to incorporate interactions between gene ex-
pression measurements, we focus on consideration of the
main eﬀects for purposes of exposition.
Suppose XD represents the gene expression proﬁle for
a typical cancer specimen (ie, g = 1), and X
¯ D is the cor-
responding proﬁle for a randomly chosen benign spec-
imen. Note that in our situation, the diagnostic test is
the linear combination βT
0 X. One relevant quantity is
the false positive rate based on a cutoﬀ c,d e ﬁ n e dt ob e
FP(c) = P(βT
0 X >c |g = 0). Similarly, the true positive
rate is TP(c) = P(βT
0 X >c |g = 1). The true and false
positive rates can be summarized by the receiver operat-
ing characteristic (ROC) curve, which is a graphical pre-
sentation of {FP(c),TP(c):−∞ <c<∞}. The ROC
curveshowsthetradeoﬀ betweenincreasingtrueandfalse
positive rates. Tests that are have {FP(c),TP(c)} values
close to (0,1) indicate perfect discriminators, while those
with {FP(c),TP(c)} values close to the 45◦ line in the
(0,1) × (0,1) plane are tests that are unable to discrim-
inate between the diseased and healthy populations. Ex-
amples of ideal and noninformative ROC curves are given
in Figures 1a and 1b.
While the speciﬁcity and sensitivity of a diagnostic
test depend on the cutoﬀ value chosen, a useful summary
measure to consider is the area under the ROC curve. It
can be shown mathematically that the area under curve is
P(βT
0 XD >β T
0 X
¯ D)(Bamber[15]).Underabinormalprob-
ability model, Su and Liu [12] showed that this quantity
is optimized using the linear discriminant function. This
motivates our choice of consideration of these variables.
Wenextpresentanalgorithmforestimationofthesefunc-
tions.
Lineardiscriminantfunctionsbyoptimalscoring
While linear discriminant analysis (LDA) is typically
calculated using matrix algebra techniques, an alternative
method of calculating them is through the use of opti-
m a ls c o r i n g( H a s t i ee ta l[ 16, 17]). In this method, the2005:2 (2005) Machine Learning With Genomic Data 149
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Figure 1. Receiver operating characteristic (ROC) curves for (a) ideal and (b) noninformative tests.
problem of classiﬁcation into two groups is reexpressed as
a regression problem based on quantities known as opti-
mal scores.
The point of optimal scoring is to turn the categor-
ical class labels into quantitative variables. Let θ(g) =
[θ(g1),...,θ(gn)]T be the n × 1 vector of quantitative
scores assigned to g for the kth class. The optimal scor-
ing problem involves ﬁnding the vector of coeﬃcients
η ≡ (η1,η 2,...,ηp) and the scoring map θ : {0,1}→R
that minimize the following average squared residual:
ASR = n−1
n 
i=1

θ

gi

−XT
i η
2. (1)
LetZbeann×2matrixwiththeithrowequalto(1,0)
if gi = 1a n d( 0 ,1) if gi = 0( i = 1,...,n). The optimal
scores are assumed to be mutually orthogonal and nor-
malized with respect to an inner product. Thus, the min-
imization of (1) is subject to the constraint N−1 ZΘ 2 =
1, where Θ = [θ(0) θ(1)]T is a 2 × 1 vector of the opti-
mal scores. Hastie et al [16] state that the minimization of
this constrained optimization problem leads to estimates
of η that are proportional to the discriminant variables
(ie, the discriminant function) in LDA. In particular, they
propose the following algorithm for the estimation of the
LDA functions
(1) Choose an initial score matrix Θ0 satisfying
ΘT
0DpΘ0 = I,w h e r eDp = ZTZ/n.L e tΘ
∗
0 = ZΘ0.
(2) Let X be the n × p matrix with ith row Xi.F i ta
linear regression model of Θ
∗
0 on X, yielding ﬁtted
values  Θ.L e t f(X) be the vector of ﬁtted regression
functions.
(3) Obtain the eigenvector matrix Φ of Θ
∗
0
T  Θ; the op-
timal scores are then Θ
∗ = Θ0Φ.
(4) Deﬁne fopt(x) = ΦT f(x).
As mentioned before, a problem with attempting to
apply standard linear discriminant function methods to
the data here is that there is not a numerically unique so-
lution because p is larger than n. Thus,some type of regu-
larizationisneeded.OurapproachisbasedontheLASSO,
which is described in the next section.
LASSOestimation
We suppose that our data are (Yi,Xi), where Yi (i =
1,...,n) is a continuous variable. The LASSO solution is
to the optimization problem of minimizing
n 
i=1

Yi − βTXi
2 +λ
p 
j=1
 βj
 , (2)
where β = (β1,...,βp)a n dλ ≥ 0 is a penalty term. Thus,
the constraint that is utilized is an L1 constraint. An al-
ternative way of formulating (2) is to minimize
n
i=1(Yi −
βTXi)2, subject to the constraint that
p
j=1 |βj|≤t.N o t e
that in the absence of the constraint, the solution is given
by the ordinary least squares (OLS) estimator. If the usual
OLS estimator satisﬁes the constraint, then the LASSO
andOLSestimatesofβ coincide.However,forsmallerval-
ues of t, some of the components of β are estimated to be
zero. In the linear regression setting, LASSO estimation
has been considered by Tibshirani [11].
For a given value of t, minimization of
n
i=1(Yi −
βTXi)2 subjecttoanL1 constraintonthecomponentsofβ
isaquadraticprogrammingproblemwith2p linearequal-
ity constraints. A sequential algorithm is given by Tibshi-
rani [11] to solve the optimization problem.
While Tibshirani [11] considered estimating coeﬃ-
cients in regression models using LASSO, our interest is
in using gene expression data to classify tumors. In par-
ticular, we seek to extend the LDA approach advocated by
Dudoit et al [7] to handle the case where p is larger than
n. We outline the proposed method in the next section.
Estimationmethods
We propose to use an optimal scoring procedure for
classiﬁcation,whereLASSOestimationisincorporated.In
the notation of the previous section, we wish to solve the
following optimization problem. Minimize
n
−1
n 
i=1

θ

gi

−XT
i η
2 +λ
p 
j=1
 ηj
  (3)
subject to the constraint N−1 ZΘ 2 = 1. Here is the out-
line for our procedure.
(1) Choose an initial score matrix Θ0 satisfying
ΘT
0DpΘ0 = I, and let Θ0 = ZΘ.150 D. Ghosh and A. M. Chinnaiyan 2005:2 (2005)
Table 1. Classiﬁcation error rates (x 100) from simulation study. Numbers in parentheses represent standard errors associated with
misclassiﬁcation rates.
Sample size π = 0.05
small eﬀects
π = 0.05
large eﬀects
π = 0.5
small eﬀects
π = 0.5
large eﬀects

n0,n 1

= (15,15)
17.31 5 .81 2 .31 1 .9
(1.65) (1.63) (1.21) (1.30)

n0,n 1

= (20,10)
20.71 9 .31 3 .31 2 .7
(1.51) (1.45) (1.35) (1.38)

n0,n 1

= (50,50)
14.21 3 .99 .88 .6
(1.15) (1.24) (1.02) (1.11)

n0,n 1

= (70,30)
18.31 7 .61 0 .29 .9
(1.17) (1.29) (1.08) (1.06)
(2) Fit a linear regression model of Θ0 on X subject to
an L1 constraint on the parameters. Deﬁne the ﬁt-
ted values Θ
∗
0 .L e t f(X) be the vector of ﬁtted re-
gression functions.
(3) ObtaintheeigenvectormatrixΦof Θ
∗
0
TΘ0;theop-
timal scores are Θ = Θ0Φ.
(4) Deﬁne fopt(x) = ΦT f(x).
Note that we are incorporating the LASSO estimation
procedure in step (2) of the algorithm. We cannot use the
algorithm of Tibshirani [11] because it is too computa-
tionally intensive for large p (number of genes). However,
it turns out that the algorithm can be ﬁt using standard
software for SVMs, which we will now describe.
Supportvectormachines
An excellent descriptions of SVMs for classiﬁcation
can be found in [18]. We provide an overview of the
method here. We assume that the data are {xi,y i} (i =
1,...,n), where xi is a d-dimensional vector and yi ∈
{−1,+1} is the class label. The goal of SVMs is to ﬁnd an
optimal separating hyperplane between the observations
with y =− 1 and those with y = 1. This problem can
be expressed as minimizing  w 2 subject to the following
constraints:
xi ·w +b ≥ 1 −ξi for yi = 1,
xi ·w +b ≤ 1 −ξi for yi =− 1,
ξi ≥ 0f o r i = 1,...,n.
(4)
Details on how to solve the optimization problem can be
found in [18, chapter 7]. In the unregularized case, ﬁtting
the LASSO model is equivalent to ﬁtting an SVM classi-
ﬁer with the following 2p × 1 n-dimensional vectors as
the inputs: g, Yk and −Yk (k = 1,...,p), deﬁned to be the
sample labels, gene expression values and their negative
values for the kth gene across the n samples. The label is
the vector y0,d e ﬁ n e dt ob e−1 for the ﬁrst entry and 1 for
the other entries. The proof of the equivalence is given in
the “appendix.” We have created a macro in R (R founda-
tion) that implements the proposed method and can be
obtained from the ﬁrst author.
As mentioned earlier, an advantage of this approach
is that most of the gene eﬀects are estimated to be ex-
actly zero. The method can also identify the genes asso-
ciated with each of the two classes. Genes whose coeﬃ-
cients are negative are associated with the class g =− 1,
while those with positive estimated coeﬃcients are associ-
ated with g = 1.
As is evident in the algorithm from the previous sec-
tion or in (3), the parameter λ needs to be estimated. We
use ﬁvefold cross-validation for this.
RESULTS AND DISCUSSION
Simulateddata
We ﬁrst performed a set of simulations to determine
how well the proposed methods were at classiﬁcation. We
generated p = 1000 dimensional vectors for two popu-
lations. We considered the following sample size combi-
nations (n0,n 1) = (15,15), (20,10), (50,50), and (70,30),
wherenk isthenumberofsamplesinthegroupwithg = k
(k = 0,1). All the genes were assumed to be independent
with a normal distribution and variance 1. We assumed
a model in which a fraction π of the genes was diﬀeren-
tially expressed between the two classes, π = 0.05 and
π = 0.5 were considered. We examined two scenarios.
For the ﬁrst scenario, there was a big change in diﬀeren-
tial expression in the diﬀerentially expressed genes, a shift
of 5 units in the mean. In the second scenario, the fold
change was only a 1.5 unit diﬀerence in mean. For each
simulation setting, 100 datasets were generated, and the
classiﬁcation error rates were estimated using three-fold
cross-validation. No optimization was performed; we set
λ = 10. The results are summarized in Table 1.B a s e do n
the table, we ﬁnd that for larger sample sizes and larger
eﬀect sizes, as well as larger numbers of eﬀects, the error
rates are smaller.
However, in our simulations (data not shown), we
found that the method had diﬃculty in selecting the cor-
rect variables when p is larger than n. This attests to the
fact that variable selection in the situation of large p and
small n is quite diﬃcult. We discuss this situation in the
“conclusion.”2005:2 (2005) Machine Learning With Genomic Data 151
Table 2. List of genes underexpressed in prostate cancer relative to benign prostate tissue.
Clone ID Gene name
Hs.288965 Homo sapiens cDNA: FLJ22300 ﬁs, clone HRC04759
Hs.76307 Neuroblastoma, suppression of tumorigenicity 1
Hs.9615 Myosin, light polypeptide 9, regulatory
Hs.226795 Glutathione S-transferase pi
Hs.171731
Solute carrier family 14 (urea transporter),
member 1 (Kidd blood group)
Prostatecancergeneexpressiondata
The example we consider is from a prostate can-
cer study; a subset of the samples was considered by
Dhanasekaran et al [3]. We focus here on noncancer ver-
sus cancer tissues. The samples are proﬁled using spotted
cDNA (ie, red/green) microarrays; there are initially 101
samples proﬁled using 10K chips (9984 genes). We have
taken the following preprocessing steps:
(1) remove genes that are reported as missing in more
than 10% of the samples;
(2) remove genes that have a variance less than 0.05 in
all samples;
(3) impute measurements for missing genes using the
median.
This leaves a total of 4880 genes for analysis.
We ﬁrst performed an estimation of the error rate us-
ing ﬁvefold cross-validation. This generally gave an error
rate between 15–20% for various choices of λ, suggest-
ing that the classiﬁer is not sensitive to the choice of the
smoothing parameter.
One of the by-products of the procedure is a list of
genes that are estimated to have non-zero eﬀects. We
present the gene lists for λ = 1i nTable 2. Out of the 4880
genes, only 21 are estimated to have nonzero eﬀects. Of
thegenesthatareoverexpressedinprostatecancerrelative
to benign prostate tissue, the early growth response (Hs.
326035/301865), feline sarcoma viral oncogene homolog
(Hs.81665), T-cell receptor gamma locus (Hs. 112259),
and fatty acid synthase (Hs.83190) have been seen by
other investigators to be upregulated in prostate cancer,
as in Table 3. The other genes on the list could represent
false positives or genes whose joint eﬀect is predictive of
cancer status.
Conclusion
In this paper, we have introduced a new approach to
the joint problems of classiﬁcation and variable selection
in the analysis of microarray data. These problems have
been treated as separate problems in the previous litera-
ture. Our approach is combine the two problems by use
of the LASSO.
This work has opened the way for several future av-
enues of research that we are currently investigating. First,
a popular alternative to LDA in classiﬁcation problems
is logistic regression. It has been recently motivated by
ROCconsiderations(McIntoshandPepe[19]).Whileitis
possible to formulate a LASSO estimation for logistic re-
gression models, adapting the LASSO-SVM equivalence
to this situation requires new algorithms. It will also be
important to compare the performance of the two L1-
regularized procedures (LDA and logistic regression) on
real and simulated microarray datasets.
In this paper, we focused on the two-class problem.
While LDA and logistic regression can be extended to
accommodate multicategorical responses, the ROC ar-
guments that motivated the method here only exist for
two populations. We are currently exploring theoretical
frameworks for generalizing ROC ideas for multiple dis-
ease states.
The estimation procedure described in this paper al-
lows the joint estimation of multivariate gene eﬀects on
the response (class label). The approach described here
could be generalized by ﬁtting more nonlinear gene ef-
fects in the estimation algorithm or by including higher-
order interactions between genes. Another generalization
is to perform a clustering of the genes and to enter the
cluster averages as covariates in the model. Such an ap-
proach was taken by Hastie et al [20] and Tibshirani et al
[21].
It is also of current interest to incorporate biologi-
cal knowledge into microarray data analyses. In many in-
stances, scientists are interested in the eﬀects of a particu-
lar gene or pathway on genetic expression. In this context,
approaches have been suggested by Zien et al [22]a n d
Pavlidis et al [23] in which biological knowledge as repre-
sented by pathway scores or functional annotation status
are correlated with gene expression. However, their ap-
proaches were univariate. There would be potential gains
in eﬃciencies of analyses by considering joint models for
pathways. We are currently studying the applicability of
the joint estimation procedure described here to that set-
ting.
Finally, a by-product of the method proposed here is
that the individual genes can be estimated to have ex-
actly zero eﬀect on the response. The list of genes with
estimated nonzero eﬀects then comprise a gene list that152 D. Ghosh and A. M. Chinnaiyan 2005:2 (2005)
Table 3. List of genes overexpressed in prostate cancer relative to benign prostate tissue.
Clone ID Gene name
Hs.326035/301865
Early growth response 1 -OR- dopachrome tautomerase
(dopachrome delta-isomerase, tyrosine-related protein 2)
Hs.299221 Pyruvate dehydrogenase kinase, isoenzyme 4
Hs.81665 v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
Hs.74267 Ribosomal protein L15
Hs.75431 Fibrinogen, gamma polypeptide
Hs.335797
ESTs, moderately similar to hypothetical protein
FLJ20097 (Homo sapiens)( H sapiens)
Hs.82129 Carbonic anhydrase III, muscle speciﬁc
Hs.112259 T-cell receptor gamma locus
Hs.151258 Hypothetical protein FLJ21062
Hs.22394 Sec3-like
Hs.84190 Solute carrier family 19 (folate transporter), member 1
Hs.119597 Stearoyl-CoA desaturase (delta-9-desaturase)
Hs.131740 Homo sapiens cDNA FLJ30428 ﬁs, clone BRACE2008941
Hs.50727 N-acetylglucosaminidase, alpha- (Sanﬁlippo disease IIIB)
Hs.83190 Fatty acid synthase
Hs.82961
Homo sapiens, clone MGC: 22588 IMAGE: 4696566,
mRNA, complete cds
investigators can do further validation work on. However,
in our simulations (data not shown), we found that the
method had diﬃculty in selecting the correct v variables.
This attests to the fact that variable selection in the situa-
tion of large p and small n is quite diﬃcult. An alternative
tothemethodproposedhereisBayesianvariableselection
methods (Lee et al [24]). We are currently exploring an
adaptation of the algorithm described here to a Bayesian
approach.
APPENDIX
If we let w = (w1,...,wp), then SVMs can be shown
to minimize  w 2 among all hyperplanes with norm 1,
subject to the constraint that gi(w · xi + b) ≥ 1f o ra l l
i = 1,...,n. The quantity 2/ w  is known as the mar-
gin. In other words, we are trying to ﬁnd the separating
hyperplane that maximizes the margin among all classi-
ﬁersthatsatisfytheinequalityconstraints.UsingLagrange
multipliers, we can formulate the optimization problem
as ﬁnding w and b to minimize
L(w,b) ≡
1
2
 w 2 −
n 
i=1
γigi
	
xi,w


+b

+γ 1, (A.1)
subject to γi ≥ 0( i = 1,...,n), where γ = (γ1,...,γ n).
Instead, we consider the dual of this problem, which is
to maximize L such that the derivatives with respect to
w and b vanish and also that γi ≥ 0( i = 1,...,n). By
diﬀerentiating (A.1)w i t hr e s p e c tt ow and b and setting
the resulting derivatives equal to 0,w eo b t a i n
∂L
∂w
= w −
n 
i=1
γigixi = 0,
∂L
∂b
=−
n 
i=1
γigi = 0.
(A.2)
Equations (A.2) yield the solutions ˆ w =
n
i=1γigixi and n
i=1γigi = 0. If we plug in the formula for ˆ w into (A.1),
theoptimizationproblembecomesoneofmaximizingthe
dual function W(η)o v e rγ ≥ 0 and
n
i=1γigi = 0, where
W(η) =
n 
j=1
γj −
1
2
n 
j,k=1
γjγkgjgk
	
xj,xk


. (A.3)
Tibshirani[11]consideredthefollowingestimationprob-
lem Minimize
n 
i=1

Yi − ZT
i β
2 (A.4)
subject to
p
j=1 |βj|≤t. Note that this minimization
problem is equivalent to minimizing (A.4)s u b j e c tt o p
j=1(β+
j + β
−
j ) ≤ t,w h e r ea+ = max(0,a)a n da− =
−min(0,−a).Wecanequivalentlyconsiderminimization
of
n 
i=1

Yi −
p 
j=1
Zijβ+
j +
p 
j=1
Zijβ
−
j
2
−C


t −
p 
j=1
β+
j −
p 
j=1
β
−
j

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subject to β+
j ≥ 0a n dβ
−
j ≥ 0, j = 1,...,p. We in-
troduce some more notation. For k = 1,...,2p,d e ﬁ n e
Wik as Zik for k = 1,...,p and −Zi(k−p−1) for k = p +
1,...,2p. Similarly, deﬁne the 2p × 1 dimensional vec-
tor η = (η1,η 2,...,η 2p)b yηj = β+
j for j = 1,...,pand
ηj = β
−
j−p−1 for j = p+1,...,2p. Thus, (A.5)c a nb ewr i t -
ten as
n 
i=1

Yi −
2p 
j=1
Wijηj
2
− C


t −
2p 
j=1
ηj

. (A.6)
The optimization problem now is to minimize (A.6)s u b -
ject to ηj ≥ 0f o rj = 1,...,2p. Expanding the squared
term in (A.6), we have
n 
i=1

Y2
i −2Yi
2p 
j=1
Wijηj −
2p 
j,k=1
ηjηkWijWik

−C


t −
2p 
j=1
ηj

.
(A.7)
Distributing the summation sign and interchanging in-
dices, (A.7)i se q u i v a l e n tt o
 Y,Y −2
2p 
j=1
	
Wj,Y


ηj
+
2p 
j,k=1
ηjηk
	
Wj,W k


−C


t −
2p 
j=1
ηj

.
(A.8)
In particular, we want to minimize (A.8).
We now reconsider the optimization problem (A.3).
Suppose we deﬁne new observations (gi,xi)( i =
1,...,2p +1 )b yg1 =− 1a n dgj = 1f o rj = 2,...,2p +1 ,
x1 = Y/t,a n dxj = Wj−1 for j = 2,...,2p +1 and param-
eters (γ1,...,γ 2p+1)b y
γ1 =
2t2
n
i=1

yi −
2p
j=1Wijηj
2 (A.9)
and γj = α1ηj−1/t for j = 2,...,2p + 1. Then the condi-
tion
2p+1
i=1 γigi = 0i se q u i v a l e n tt oγ1 =
2p+1
i=2 γi,w h i c h
after further algebraic simpliﬁcation, yields
2p
j=1ηj = t.
Considerable algebraic simpliﬁcation gives that maximiz-
ing (A.3) can be rewritten as a problem of maximizing
2α1 −
1
2
α2
1
t2  Y,Y  +
α2
1
t2
2p 
j=1
ηj
	
Wj,Y


−
1
2
α2
1
t2
2p 
j,k=1
ηjηkgj
	
Wj,W k


(A.10)
subject to η ≥ 0a n d
2p
j=1ηj = t.B e c a u s eα1 ≥ 0,
comparison of problems (A.10)a n d( A.8) reveal that they
should yield the same solution.
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